A Complete Response After Pseudo-progression: Pembrolizumab for Metastatic Squamous Cell Carcinoma (SCC) of the Bladder

被引：5
作者：
Kao, Chester [1 ]
McNamara, Megan [1 ,2 ,3 ]
Alley, Chris [4 ]
Spector, Neil [1 ,2 ,3 ]
Jauhari, Shekeab [1 ]
Gupta, Rajan T. [5 ]
Zhang, Tian [1 ,2 ]
Zhu, Jason [1 ]
机构：
[1] Duke Univ, Dept Med, Durham, NC USA
[2] Duke Univ, Duke Canc Inst, Durham, NC USA
[3] Durham VA Med Ctr, Dept Hematol & Oncol, Durham, NC USA
[4] Duke Univ, Dept Pathol, Durham, NC 27706 USA
[5] Duke Univ, Dept Radiol, Durham, NC 27710 USA
来源：
CLINICAL GENITOURINARY CANCER | 2019年 / 17卷 / 03期
关键词：
Bladder cancer; Cisplatin ineligible; Immune checkpoint inhibitors; Metastatic bladder squamous cell carcinoma; PD-1; inhibitor; Psuedoprogression; IMMUNE-RELATED RESPONSE; RADICAL CYSTECTOMY; CISPLATIN; SURVIVAL; THERAPY; PSEUDOPROGRESSION; METHOTREXATE; VINBLASTINE; DOXORUBICIN; OUTCOMES;
D O I：
10.1016/j.clgc.2019.03.019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E672 / E677
页数：6
相关论文
共 50 条
[31]   Pembrolizumab for recurrent locally advanced or metastatic squamous cell carcinoma of the esophagus: a drug safety evaluation [J].
Yamamoto, Kazumasa ;
Yamamoto, Shun ;
Kato, Ken .
EXPERT OPINION ON DRUG SAFETY, 2024, 23 (06) :667-675
[32]   Effects of Pembrolizumab in Recurrent/Metastatic Squamous Cell Head and Neck Carcinoma: A Multicenter Retrospective Study [J].
Okada, Takuro ;
Fushimi, Chihiro ;
Matsuki, Takashi ;
Tokashiki, Kunihiko ;
Takahashi, Hideaki ;
Okamoto, Isaku ;
Sato, Hiroki ;
Kondo, Takahito ;
Hanyu, Kenji ;
Kishida, Takuma ;
Ito, Tatsuya ;
Yamashita, Gai ;
Masubuchi, Tatsuo ;
Tada, Yuichiro ;
Miura, Koki ;
Omura, Go ;
Yamashita, Taku ;
Oridate, Nobuhiko ;
Tsukahara, Kiyoaki .
ANTICANCER RESEARCH, 2023, 43 (06) :2717-2724
[33]   Risk factors for recurrence of esophageal squamous cell carcinoma after pathological complete response to neoadjuvant therapy followed by esophagectomy [J].
Hirohata, Ryosuke ;
Hamai, Yoichi ;
Emi, Manabu ;
Ibuki, Yuta ;
Kurokawa, Tomoaki ;
Ohsawa, Manato ;
Kitasaki, Nao ;
Okada, Morihito .
WORLD JOURNAL OF SURGERY, 2024, 48 (07) :1700-1709
[34]   Chemoimmunotherapy after progression on single-agent pembrolizumab for metastatic urothelial carcinoma: a case series [J].
Childs, Daniel S. ;
Quevedo, J. Fernando ;
Costello, Brian A. ;
Pagliaro, Lance C. .
ANTI-CANCER DRUGS, 2021, 32 (09) :986-990
[35]   Radiomics nomogram combined with clinical factors for predicting pathological complete response in resectable esophageal squamous cell carcinoma [J].
Lu, Zihao ;
Li, Yongsen ;
Hu, Wenxuan ;
Cao, Yonghao ;
Lv, Xin ;
Jia, Xinyu ;
Shen, Shiyu ;
Zhao, Jun ;
Xu, Chun .
FRONTIERS IN ONCOLOGY, 2024, 14
[36]   Isolated adrenocorticotropic hormone deficiency potentially induced by nivolumab following pseudo-progression in clear cell renal cell carcinoma: A case report [J].
Furubayashi, Nobuki ;
Negishi, Takahito ;
Uozumi, Tomoharu ;
Takamatsu, Dai ;
Shiraishi, Koichi ;
Hirose, Daisuke ;
Nakamura, Motonobu .
MOLECULAR AND CLINICAL ONCOLOGY, 2019, 10 (02) :304-308
[37]   Managing Metastatic Renal Cell Carcinoma after Progression on Immunotherapy [J].
Barragan-Carrillo, Regina ;
Govindarajan, Ameish ;
Rock, Adam ;
Sperandio, Rubens C. ;
Pal, Sumanta K. .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (05) :965-976
[38]   Pembrolizumab and axitinib induced pathological complete response in metastatic clear cell renal cell carcinoma with inferior vena cava thrombus: A case report [J].
Wong, Ryan ;
Rose, Tracy L. ;
Tan, Hung-Jui ;
Hansen, Christina ;
Wobker, Sara E. ;
Bjurlin, Marc .
SAGE OPEN MEDICAL CASE REPORTS, 2025, 13
[39]   Post-chemo-radiotherapy response and pseudo-progression evaluation on glioma cell types by multi-parametric magnetic resonance imaging: a prospective study [J].
Zamanian, Maryam ;
Abedi, Iraj ;
Danazadeh, Fatemeh ;
Amouheidari, Alireza ;
Shahreza, Bentolhoda Otroshi .
BMC MEDICAL IMAGING, 2023, 23 (01)
[40]   Pathological complete response after neoadjuvant treatment determines survival in esophageal squamous cell carcinoma patients (NEOCRTEC5010) [J].
Shen, Jianfei ;
Kong, Min ;
Yang, Hong ;
Jin, Ke ;
Chen, Yuping ;
Fang, Wentao ;
Yu, Zhentao ;
Mao, Weimin ;
Xiang, Jiaqing ;
Han, Yongtao ;
Chen, Zhijian ;
Yang, Haihua ;
Wang, Jiaming ;
Pang, Qingsong ;
Zheng, Xiao ;
Li, Tao ;
Zhang, Xu ;
Li, Qun ;
Wang, Geng ;
Mao, Teng ;
Guo, Xufeng ;
Lin, Ting ;
Liu, Mengzhong ;
Ma, Dehua ;
Ye, Minhua ;
Wang, Chunguo ;
Wang, Zheng ;
Brunelli, Alessandro ;
Cerfolio, Robert J. ;
D'Journo, Xavier Benoit ;
Fernando, Hiran C. ;
Lordick, Florian ;
Fu, Jianhua ;
Chen, Baofu ;
Zhu, Chengchu .
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (20)
12345